Search - tctmd.com

Displaying 421 - 440 of 747

Sort: Relevancy | Date

News Conference News EuroPCR 2013

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Jason Kahn

May 21, 2013

News Daily News

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

L.A. McKeown

May 13, 2013

News Daily News

Obesity Paradox Revisited: Lower BMI Linked to Higher Death, CV Events After PCI

L.A. McKeown

May 13, 2013

Presentation

Angioplasty Following Carotid Stent Deployment Reduces the Risk of Restenosis and May or May Not Increase the Risk of Procedure-Related Stroke

Presenter: Mahmoud B. Malas

May 09, 2013

News Conference News SCAI 2013

CREST Subanalysis: Post Carotid Stent Balloon Dilatation May Reduce Restenosis

Jason Kahn

May 09, 2013

News Daily News

NEXT Published: Biodegradable Polymer BES Shows Noninferiority to EES

Yael L. Maxwell

May 08, 2013

News Daily News

NEXT Publicado: Los SLB de Polímero Biodegradable No son Inferiores a los SLE

Yael L. Maxwell

May 08, 2013

News Industry News

Cardiovascular Summit TCTAP 2013 Symposium to Feature OrbusNeich’s COMBO Dual Therapy Stent™

April 22, 2013

News Daily News

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

L.A. McKeown

April 19, 2013

News Daily News

Stenting Shows Positive Results in Mesenteric Artery CTO Lesions

Yael L. Maxwell

April 19, 2013

News Daily News

Mortality Varies by Revascularization Method in Dialysis Patients

Caitlin E. Cox

April 19, 2013

News Daily News

La Colchicina Reduce la Reestenosis de los SMD en Pacientes Diabéticos

April 19, 2013

News Daily News

Colchicine Reduces BMS Restenosis in Diabetic Patients

April 19, 2013

Presentation

Colchicine Treatment for Prevention of In-BMS Restenosis in Diabetics

Presenter: S. Deftereos

April 17, 2013

Presentation Fellows 2013

Stent Complications: Restenosis and Thrombosis

Presenter: Ajay Kirtane

April 15, 2013

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

News Daily News

REMEDEE Published: ‘Dual Therapy’ Stent Passes Early Efficacy, Safety Tests

April 05, 2013

News Daily News

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

L.A. McKeown

April 05, 2013

News Daily News

Pair of Studies Support Paclitaxel-Eluting Devices for Treating Femoropopliteal Disease

Caitlin E. Cox

April 05, 2013

News Daily News

2 Estudios Avalan el Uso de Dispositivos liberadores de Paclitaxel en el Tratamiento de la Enfermedad Femoropoplítea

Caitlin E. Cox

April 05, 2013

Advertisement

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

Obesity Paradox Revisited: Lower BMI Linked to Higher Death, CV Events After PCI

Angioplasty Following Carotid Stent Deployment Reduces the Risk of Restenosis and May or May Not Increase the Risk of Procedure-Related Stroke

CREST Subanalysis: Post Carotid Stent Balloon Dilatation May Reduce Restenosis

NEXT Published: Biodegradable Polymer BES Shows Noninferiority to EES

NEXT Publicado: Los SLB de Polímero Biodegradable No son Inferiores a los SLE

Cardiovascular Summit TCTAP 2013 Symposium to Feature OrbusNeich’s COMBO Dual Therapy Stent™

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

Stenting Shows Positive Results in Mesenteric Artery CTO Lesions

Mortality Varies by Revascularization Method in Dialysis Patients

La Colchicina Reduce la Reestenosis de los SMD en Pacientes Diabéticos

Colchicine Reduces BMS Restenosis in Diabetic Patients

Colchicine Treatment for Prevention of In-BMS Restenosis in Diabetics

Stent Complications: Restenosis and Thrombosis

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

REMEDEE Published: ‘Dual Therapy’ Stent Passes Early Efficacy, Safety Tests

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

Pair of Studies Support Paclitaxel-Eluting Devices for Treating Femoropopliteal Disease

2 Estudios Avalan el Uso de Dispositivos liberadores de Paclitaxel en el Tratamiento de la Enfermedad Femoropoplítea

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content